Cargando…

Adenosine Receptor Antagonists to Combat Cancer and to Boost Anti-Cancer Chemotherapy and Immunotherapy

Extracellular adenosine accumulates in the environment of numerous tumors. For years, this fact has fueled preclinical research to determine whether adenosine receptors (ARs) could be the target to fight cancer. The four ARs discovered so far, A(1), A(2A), A(2B) and A(3), belong to the class A famil...

Descripción completa

Detalles Bibliográficos
Autores principales:	Franco, Rafael, Rivas-Santisteban, Rafael, Navarro, Gemma, Reyes-Resina, Irene
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8616521/ https://www.ncbi.nlm.nih.gov/pubmed/34831054 http://dx.doi.org/10.3390/cells10112831

Ejemplares similares

The Old and New Visions of Biased Agonism Through the Prism of Adenosine Receptor Signaling and Receptor/Receptor and Receptor/Protein Interactions
por: Franco, Rafael, et al.
Publicado: (2021)

Microglial Adenosine Receptors: From Preconditioning to Modulating the M1/M2 Balance in Activated Cells
por: Franco, Rafael, et al.
Publicado: (2021)

Genes Implicated in Familial Parkinson’s Disease Provide a Dual Picture of Nigral Dopaminergic Neurodegeneration with Mitochondria Taking Center Stage
por: Franco, Rafael, et al.
Publicado: (2021)

Experimental and computational analysis of biased agonism on full-length and a C-terminally truncated adenosine A(2A) receptor
por: Navarro, Gemma, et al.
Publicado: (2020)

Microbiota and Other Preventive Strategies and Non-genetic Risk Factors in Parkinson’s Disease
por: Franco, Rafael, et al.
Publicado: (2020)

5-Hydroxytryptamine, Glutamate, and ATP: Much More Than Neurotransmitters
por: Franco, Rafael, et al.
Publicado: (2021)

Adenosine A(2A) Receptor Antagonists Affects NMDA Glutamate Receptor Function. Potential to Address Neurodegeneration in Alzheimer’s Disease
por: Franco, Rafael, et al.
Publicado: (2020)

Adenosine A(2A) and A(3) Receptors Are Able to Interact with Each Other. A Further Piece in the Puzzle of Adenosine Receptor-Mediated Signaling
por: Lillo, Alejandro, et al.
Publicado: (2020)

Angiotensin AT(1) and AT(2) receptor heteromer expression in the hemilesioned rat model of Parkinson’s disease that increases with levodopa-induced dyskinesia
por: Rivas-Santisteban, Rafael, et al.
Publicado: (2020)

Functional Complexes of Angiotensin-Converting Enzyme 2 and Renin-Angiotensin System Receptors: Expression in Adult but Not Fetal Lung Tissue
por: Franco, Rafael, et al.
Publicado: (2020)

Antagonization of OX(1) Receptor Potentiates CB(2) Receptor Function in Microglia from APP(Sw/Ind) Mice Model
por: Raïch, Iu, et al.
Publicado: (2022)

Adenosine A(2A) Receptor Antagonists in Neurodegenerative Diseases: Huge Potential and Huge Challenges
por: Franco, Rafael, et al.
Publicado: (2018)

Dopamine in Health and Disease: Much More Than a Neurotransmitter
por: Franco, Rafael, et al.
Publicado: (2021)

Methamphetamine Blocks Adenosine A(2A) Receptor Activation via Sigma 1 and Cannabinoid CB(1) Receptors
por: Casanovas, Mireia, et al.
Publicado: (2021)

The Binding Mode to Orthosteric Sites and/or Exosites Underlies the Therapeutic Potential of Drugs Targeting Cannabinoid CB(2) Receptors
por: Franco, Rafael, et al.
Publicado: (2022)

The NADPH Link between the Renin Angiotensin System and the Antioxidant Mechanisms in Dopaminergic Neurons
por: Franco, Rafael, et al.
Publicado: (2023)

Natural Compounds as Guides for the Discovery of Drugs Targeting G-Protein-Coupled Receptors
por: Serrano-Marín, Joan, et al.
Publicado: (2020)

Cannabigerol Action at Cannabinoid CB(1) and CB(2) Receptors and at CB(1)–CB(2) Heteroreceptor Complexes
por: Navarro, Gemma, et al.
Publicado: (2018)

The Expression of Cellular Prion Protein, PrPC, Favors pTau Propagation and Blocks NMDAR Signaling in Primary Cortical Neurons
por: Rivas-Santisteban, Rafael, et al.
Publicado: (2023)

Targeting adenosine for cancer immunotherapy
por: Leone, Robert D., et al.
Publicado: (2018)

Tumor Immunotherapy Using A(2A) Adenosine Receptor Antagonists
por: Zhang, Jinfeng, et al.
Publicado: (2020)

CXCR2 Small-Molecule Antagonist Combats Chemoresistance and Enhances Immunotherapy in Triple-Negative Breast Cancer
por: Ghallab, Alaa M., et al.
Publicado: (2022)

Identification of the Ghrelin and Cannabinoid CB(2) Receptor Heteromer Functionality and Marked Upregulation in Striatal Neurons from Offspring of Mice under a High-Fat Diet
por: Lillo, Jaume, et al.
Publicado: (2021)

Differential Gene Expression in Activated Microglia Treated with Adenosine A(2A) Receptor Antagonists Highlights Olfactory Receptor 56 and T-Cell Activation GTPase-Activating Protein 1 as Potential Biomarkers of the Polarization of Activated Microglia
por: Lillo, Alejandro, et al.
Publicado: (2023)

Novel Interactions Involving the Mas Receptor Show Potential of the Renin–Angiotensin system in the Regulation of Microglia Activation: Altered Expression in Parkinsonism and Dyskinesia
por: Rivas-Santisteban, Rafael, et al.
Publicado: (2021)

N-Methyl-D-aspartate (NMDA) and cannabinoid CB(2) receptors form functional complexes in cells of the central nervous system: insights into the therapeutic potential of neuronal and microglial NMDA receptors
por: Rivas-Santisteban, Rafael, et al.
Publicado: (2021)

Chemotherapy vs. Immunotherapy in combating nCOVID19: An update
por: Choudhury, Abhigyan, et al.
Publicado: (2021)

Targeting Adenosine Receptor Signaling in Cancer Immunotherapy
por: Sek, Kevin, et al.
Publicado: (2018)

Editorial: Adenosine pathways in cancer immunity and immunotherapy
por: Fu, Junjiang, et al.
Publicado: (2023)

Striatal Pre- and Postsynaptic Profile of Adenosine A(2A) Receptor Antagonists
por: Orru, Marco, et al.
Publicado: (2011)

Expression of Melatonin and Dopamine D(3) Receptor Heteromers in Eye Ciliary Body Epithelial Cells and Negative Correlation with Ocular Hypertension
por: Reyes-Resina, Irene, et al.
Publicado: (2020)

Understanding the Role of Adenosine A2AR Heteroreceptor Complexes in Neurodegeneration and Neuroinflammation
por: Borroto-Escuela, Dasiel O., et al.
Publicado: (2018)

Epigenetic Strategies to Boost Cancer Immunotherapies
por: Barrero, Maria J.
Publicado: (2017)

Smart Design of Nanostructures for Boosting Tumor Immunogenicity in Cancer Immunotherapy
por: Yin, Bohan, et al.
Publicado: (2023)

Targeting Adenosine in Cancer Immunotherapy to Enhance T-Cell Function
por: Vigano, Selena, et al.
Publicado: (2019)

Adenosine Blockage in Tumor Microenvironment and Improvement of Cancer Immunotherapy
por: Arab, Samaneh, et al.
Publicado: (2019)

Adenosine signaling: Optimal target for gastric cancer immunotherapy
por: Wang, Junqing, et al.
Publicado: (2022)

Immunosuppressive adenosine-targeted biomaterials for emerging cancer immunotherapy
por: Wei, Qi, et al.
Publicado: (2022)

Manipulation of Glucose Availability to Boost Cancer Immunotherapies
por: Marchesi, Federica, et al.
Publicado: (2020)

Large cash boost to combat avian influenza
por: Brierley, Rob
Publicado: (2006)

Cannot write session to /tmp/vufind_sessions/sess_9gkmeak9mqhphp85btpj7frefs